FRAME - tumor genome-based personalized anti-cancer vaccines off-the-shelf

Project description

Frame-shift mutation based anticancer vaccination

Fields of science

• medical and health sciences › basic medicine › pharmacology and pharmacy › pharmaceutical drug › vaccines
• natural sciences › biological sciences › genetics and heredity › mutation
• medical and health sciences › basic medicine › immunology
• medical and health sciences › clinical medicine › cancer

Programme(s)

• H2020-EU.3. - PRIORITY 'Societal challenges
• H2020-EU.2.3. - INDUSTRIAL LEADERSHIP - Innovation In SMEs
• H2020-EU.2.1. - INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies

Topic(s)

• EIC-SMEInst-2018-2020 - SME instrument

Call for proposal

H2020-SMEInst-2018-2020-1
See other projects for this call

Funding Scheme

SME-1 - SME instrument phase 1

Coordinator

FRAME PHARMACEUTICALS BV

Address

Science Park 106
1098 XG Amsterdam
Netherlands

Activity type

Private for-profit entities (excluding Higher or Secondary Education Establishments)

EU contribution

€ 50 000